Pieris Pharmaceuticals falls on lower Q4 revenue

Palvella Therapeutics

29/03/2023 18:23

** Shares of Pieris Pharmaceuticals Inc  PIRS.O  fall 23.6%
to a near 3-month low of $1.13
    ** Co reports drop in Q4 rev to $25.9 mln from $31.4 mln a
year earlier
    ** Posts Q4 net loss of 45 cents per share vs net loss of 71
cents per share in Q4 2021
    ** Ended 2022 with cash, cash equivalents, and investments
of $59.2 mln, sufficient to fund operations for more than 12
months - co
    ** Including session losses, shares up ~12% YTD

 (Reporting by Yamini Kalia)
 ((Yamini.Kalia@thomsonreuters.com))